| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2019 | Aug 8, 2019 | Vyome Holdings, Inc | 10% Owner | Buy | 100.0 | +250,000 | 44.37% | ✗ | $1M |
| Aug 23, 2018 | Aug 27, 2018 | Vyome Holdings, Inc | 10% Owner | Buy | 100.0 | +1,648,359 | 41.35% | ✗ | $3M |
| May 26, 2016 | May 27, 2016 | Evoke Pharma Inc | 10% Owner | Sell | 17.5 | -344,120 | -36.21% | ✗ | $1.6M |
| Apr 25, 2016 | Apr 27, 2016 | Evoke Pharma Inc | 10% Owner | Sell | 36.3 | -5,095 | -0.53% | ✗ | $25.8K |
| Apr 19, 2016 | Apr 21, 2016 | Evoke Pharma Inc | 10% Owner | Sell | 22.5 | -41,478 | -4.16% | ✗ | $222K |
| Apr 11, 2016 | Apr 13, 2016 | Evoke Pharma Inc | 10% Owner | Sell | 43.8 | -4,348 | -0.43% | ✗ | $22.7K |
| Apr 6, 2016 | Apr 8, 2016 | Evoke Pharma Inc | 10% Owner | Sell | 20.0 | -51,004 | -4.85% | ✗ | $269.2K |
| Aug 18, 2015 | Aug 20, 2015 | Evoke Pharma Inc | 10% Owner | Sell | 22.5 | -11,836 | -1.11% | ✗ | $83.1K |
| Apr 14, 2015 | Apr 16, 2015 | Evoke Pharma Inc | 10% Owner | Sell | 20.0 | -50,163 | -4.50% | ✗ | $365.7K |
| Nov 25, 2014 | Dec 10, 2014 | Evofem Biosciences, Inc. | 10% Owner | Sell | 27.5 | -87,317 | -0.95% | ✗ | $1.2M |
| Nov 25, 2014 | Nov 26, 2014 | Evofem Biosciences, Inc. | 10% Owner | Sell | 27.5 | -87,317 | -0.95% | ✗ | $1.2M |
| Oct 21, 2014 | Oct 21, 2014 | Esperion Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +500,000 | 24.19% | ✗ | $10M |
| Jul 1, 2013 | Jul 2, 2013 | Esperion Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +280,923 | 15.73% | ✗ | $3.9M |